Clinical Trial Update: A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Dolphin Protect Catheter

View source ↗

Summary

A completed post-market clinical performance and safety evaluation of the GamCath HighFlow Dolphin Protect Catheter, assessing its real-world safety and perform…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Kidney Injury
• Renal Failure

Drugs mentioned

• GamCath HighFlow Dolphin Protect Catheter

Snippet

Sponsor: Vantive Health LLC | Conditions: AKI - Acute Kidney Injury, Acute Renal Failure | Status: COMPLETED